Uniphos Enterprises Limited (IN:UNIENTER)
:UNIENTER
Want to see IN:UNIENTER full AI Analyst Report?
Top Page
Uniphos Enterprises Limited
(UNIENTER)
Select Model
Select Model
Rating:49Neutral
Price Target:
₹109.00
▼(-25.01% Downside)
Action:Reiterated
Date:06/16/26
The score is primarily held back by weak and volatile operating performance and uneven cash-flow support for earnings, despite a notably low financial-risk balance sheet (debt-free). Technicals are mixed with a modest near-term recovery but a weaker long-term trend, and valuation is a headwind given the high P/E and low dividend yield.
Positive Factors
Debt-free balance sheet
Zero reported debt is a durable defensive advantage: it materially lowers bankruptcy risk, preserves borrowing optionality, and gives management flexibility to fund investments, support subsidiaries, or weather cyclical industry stress without immediate refinancing pressure.
Negative Factors
Highly volatile and shrinking revenue
Large, persistent revenue swings undermine visibility and planning, impede earnings predictability, and make it hard to build sustainable operating margins. Structural revenue instability increases the probability that profits rely on one-off gains and not repeatable business performance.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
Zero reported debt is a durable defensive advantage: it materially lowers bankruptcy risk, preserves borrowing optionality, and gives management flexibility to fund investments, support subsidiaries, or weather cyclical industry stress without immediate refinancing pressure.
Read all positive factors
Uniphos Enterprises Limited (UNIENTER) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.55B
Dividend Yield0.34%
Average Volume (3M)1.50K
Price to Earnings (P/E)36.5
Beta (1Y)1.03
Revenue Growth-71.30%
EPS Growth7347.75%
CountryIN
Employees2,022
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)2.72
Shares Outstanding69,545,845
10 Day Avg. Volume885
30 Day Avg. Volume1,505
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.26
Price to Sales (P/S)19.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Uniphos Enterprises Limited Business Overview & Revenue Model
Company Description
Uniphos Enterprises Limited, primarily operating in India, is involved in the trade of chemical products and various other goods. It also makes investments in both publicly listed and unlisted securities. The company was founded in 1969 and has it...
How the Company Makes Money
Uniphos Enterprises Limited primarily makes money through income generated from its investment and holding activities. Key revenue/earnings sources typically include: (1) dividends and other distributions received from investee companies or group ...
Uniphos Enterprises Limited Financial Statement Overview
Summary
Income Statement
36
Negative
Balance Sheet
78
Positive
Cash Flow
41
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 838.64M | 320.03M | 1.12B | 506.48M | 14.72M | 12.22M |
| Gross Profit | 3.63M | -18.27M | 8.02M | 652.00K | 164.00K | -11.00K |
| EBITDA | 208.31M | -37.20M | 22.99M | -30.90M | -28.63M | -31.26M |
| Net Income | 189.89M | 207.11M | 2.78M | 386.14M | 392.25M | 546.04M |
Balance Sheet | ||||||
| Total Assets | 29.62B | 26.19B | 28.42B | 20.78B | 30.95B | 33.02B |
| Cash, Cash Equivalents and Short-Term Investments | 223.74M | 209.51M | 162.37M | 469.95M | 517.30M | 391.46M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.18B | 1.72B | 1.00B | 20.50M | 978.68M | 1.21B |
| Stockholders Equity | 28.44B | 24.47B | 27.42B | 20.75B | 29.98B | 31.81B |
Cash Flow | ||||||
| Free Cash Flow | -20.75M | 0.00 | -27.17M | -34.67M | -14.66M | 5.20M |
| Operating Cash Flow | -20.75M | 213.92M | -27.17M | -34.67M | -14.66M | 5.20M |
| Investing Cash Flow | 65.05M | -148.99M | 527.70M | 501.62M | 406.29M | 204.34M |
| Financing Cash Flow | -34.77M | -34.77M | -409.58M | -452.05M | -392.93M | -236.46M |
Uniphos Enterprises Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ₹11.00B | 30.21 | ― | 0.26% | -13.58% | -10.91% | |
65 Neutral | ₹9.69B | 12.66 | ― | 0.38% | 7.53% | 36.87% | |
63 Neutral | ₹12.44B | 19.47 | ― | 0.24% | 14.36% | 64.31% | |
62 Neutral | ₹6.20B | 22.75 | ― | 0.97% | 34.84% | 26.96% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | ₹8.72B | 26.20 | ― | ― | 2.78% | ― | |
49 Neutral | ₹7.55B | 36.45 | ― | 0.34% | -71.30% | 7347.75% |
* Basic Materials Sector Average
IN:UNIENTER
Uniphos Enterprises Limited
108.70
-39.86
-26.83%
IN:AMNPLST
Amines & Plasticizers Ltd.
195.00
-41.48
-17.54%
IN:DMCC
DMCC Speciality Chemicals Limited
252.20
-3.93
-1.53%
IN:INDOAMIN
Indo Amines Limited
143.40
-4.13
-2.80%
IN:PUNJABCHEM
Punjab Chemicals & Crop Protection Ltd.
1,047.60
-147.49
-12.34%
IN:VALIANTORG
Valiant Organics Limited
291.45
-124.65
-29.96%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.